한글목차

세계의 조류인플루엔자 시장은 2025년에는 15억 8,000만 달러로 추정되고, 2032년에는 22억 4,000만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 성장률(CAGR) 5.1%로 성장할 전망입니다.

조류인플루엔자(조류 A형 인플루엔자)는 일반적으로 야생의 물새와 종달새에 감염된 인플루엔자 바이러스로 인한 질병을 가리킵니다. 드물게, 이러한 바이러스는 가금류나 기타 조류, 동물, 그리고 인간에게도 감염될 수 있습니다. 지난 20년 동안 가금류에 심각한 질병을 일으켜 인간의 심각한 질병이나 죽음으로 이어지는 것도 있는 여러 아형 조류 인플루엔자 바이러스가 출현했습니다. 1997-2006년 고병원성 조류인플루엔자A(H5N1) 바이러스의 세계적 유행은 그 팬데믹(세계적 대유행) 가능성에 큰 우려를 불러일으켰습니다. 지속적인 사람 간 감염은 기록되지 않은 반면 산발적인 사람 간 감염 사례가 끊이지 않으며, 그 주요 원인은 감염된 살아있는 가금류나 죽은 가금류와의 접촉입니다.

시장 역학 :

세계의 조류인플루엔자 시장은 막대한 경제적 손실로 이어지는 양계장에서 조류인플루엔자의 주기적 발생, 바이러스 돌연변이 및 인간에 대한 유행의 가능성 증가, 조류인플루엔자 바이러스의 예방, 관리 및 감시에 대한 정부의 관심 증가 등의 요인에 의해 성장을 이끌고 있습니다. 러나 많은 개발도상국에서는 조류독감에 대한 인식이 낮다는 점, 상업용 가금류 백신 접종 프로그램이 어렵다는 점, 효과적인 항바이러스제 및 백신 개발에 높은 비용이 드는 점 등이 시장의 성장을 억제하고 있습니다. 신규 포인트 오브 케어 진단 기술의 개발과 신흥 경제국에 의한 예방 및 관리 대책의 개선은 시장 확대의 호기입니다.

예를 들어 2023년 3월 바이러스성 질환의 예방, 검출, 진단에 주력하는 혁신적인 진단 회사인 Virax Biolabs Group Limited는 조류인플루엔자 A 바이러스 실시간 PCR 검사 키트를 CE 마크 시장 : 즉 유럽 연합에 판매한다고 발표했습니다. 이 검사 키트는 현재 유럽에서 유행하는 H5N1주를 포함한 AIV 및 H5, H7, H9 아형의 리보핵산을 검출하여 구분합니다.

본 조사의 주요 특징

• 본 보고서는 세계의 조류인플루엔자 시장을 상세하게 분석하여 2024년을 기준연도로 하여 예측 기간(2025-2032년) 시장 규모 및 복합 연간 성장률(CAGR)을 제공합니다.
• 또, 다른 부문에 걸친 잠재적인 수익 성장 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 다음 파라미터에 근거하여, 세계의 조류인플루엔자 시장에서 주요 기업을 프로파일링하고 있습니다.
• 이 보고서의 마케팅 담당자나 기업의 경영진은 장래의 제품의 발매, 유형의 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 세계의 조류인플루엔자 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자를 지원합니다.
• 이해관계자는 세계 조류인플루엔자 시장의 분석에 사용되는 다양한 전략 매트릭스를 통해, 의사 결정이 용이하게 됩니다.

목차

제1장 조사의 목적 및 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의 및 범위
• 주요 요약
• 일관된 기회 지도(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시 및 승인
• PEST 분석
• Porter's Five Forces 분석
• 합병 및 인수 시나리오

제4장 세계의 조류인플루엔자 시장 : 코로나 바이러스(COVID-19) 유행의 영향

• COVID-19 역학
• 공급측 및 수요측 분석
• 경제에 미치는 영향

제5장 세계의 조류인플루엔자 시장 : 바이러스 유형별(2020-2032년)

• H5N1
• H7N9
• H5N6
• H5N8
• H10N8
• H9N2
• 기타

제6장 세계의 조류인플루엔자 시장 : 검사 유형별(2020-2032년)

• PCR 검사
• ELISA 검사
• 혈구 응집 반응 분석
• 바이러스 분리 시험
• 차세대 시퀀싱
• 기타

제7장 세계의 조류인플루엔자 시장 : 치료 유형별(2020-2032년)

• 백신
• 항바이러스제
• 면역조절제
• 기타

제8장 세계의 조류인플루엔자 시장 : 동물 유형별(2020-2032년)

• 닭
• 오리
• 거위 및 백조
• 비둘기
• 호랑나비
• 칠면조
• 기타

제9장 세계의 조류인플루엔자 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙 아프리카
  • 남아프리카

제10장 경쟁 구도

• Boehringer Ingelheim
• Ceva Sante Animale
• Zoetis
• Merck & Co.
• Ringpu Biology
• Yebio Bioengineering
• FATRO
• CAVAC
• ChengDu Tecbond
• QYH Biotech
• Elanco
• Phibro Animal Health
• Vetoquinol
• Hipra
• Venkys
• Anicon Labor GmbH
• Medion Farma Jaya
• Bioveta
• Lohmann Animal Health
• Biogenesis Bago

제11장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Global Bird Flu Market is estimated to be valued at USD 1.58 Bn in 2025 and is expected to reach USD 2.24 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.

Bird flu, or avian influenza, refers to the diseases caused by influenza viruses that normally infect wild waterfowl and shorebirds. On rare occasions, these viruses can infect poultry and other bird and animal species, as well as humans. Over the past two decades, several subtypes of avian influenza viruses have emerged which can cause severe disease in poultry and some lead to serious illness or death in humans. The global spread of highly pathogenic avian influenza A (H5N1) virus from 1997 to 2006 raised considerable concern for its pandemic potential. While no sustained human-to-human transmission has been documented, sporadic human cases continue to occur, predominantly linked to contact with infected live or dead poultry.

Market Dynamics:

Global bird flu market growth is driven by factors such as the cyclic outbreaks of avian influenza in poultry farms which lead to huge economic losses, increasing risk of virus mutation and potential human pandemic, and rising government focus on prevention, control and surveillance of avian influenza viruses. However, factors such as lack of awareness regarding avian influenza in many developing countries, difficulties associated with vaccination programs in commercial poultry, and high costs related to developing effective anti-viral drugs and vaccines are restraining the market growth. The development of novel point-of-care diagnostic technologies and emerging economies improving prevention and control measures present high-impact opportunities for market expansion.

For instance, in March 2023, Virax Biolabs Group Limited, an innovative diagnostics company that focuses on the prevention, detection, and diagnosis of viral diseases, announced the distribution of an Avian Influenza A Virus real-time PCR test kit to CE-marked markets, namely the European Union. The test kit detects and distinguishes ribonucleic acid from AIV and the H5, H7, and H9 subtypes, including the H5N1 strain presently circulating in Europe.

Key Features of the Study:

• This report provides an in-depth analysis of the global bird flu market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bird flu market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Boehringer Ingelheim, Ceva Sante Animale, Zoetis, Merck & Co., Ringpu Biology, Yebio Bioengineering, FATRO, CAVAC, ChengDu Tecbond, QYH Biotech, Elanco, Phibro Animal Health, Vetoquinol, Hipra, Venkys, Anicon Labor GmbH, Medion Farma Jaya, Bioveta, Lohmann Animal Health, and Biogenesis Bago
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global bird flu market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bird flu market

Global Bird Flu Market Detailed Segmentation:

• By Virus Type:
  • H5N1
  • H7N9
  • H5N6
  • H5N8
  • H10N8
  • H9N2
  • Others
• By Test Type:
  • PCR Tests
  • ELISA Tests
  • Hemagglutination Assays
  • Virus Isolation Tests
  • Next Generation Sequencing
  • Others
• By Treatment Type:
  • Vaccines
  • Antiviral Medication
  • Immunomodulators
  • Others
• By Animal Type:
  • Chickens
  • Ducks
  • Geese & Swans
  • Pigeons
  • Guinea Fowls
  • Turkeys
  • Others
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Zoetis
  • Merck & Co.
  • Ringpu Biology
  • Yebio Bioengineering
  • FATRO
  • CAVAC
  • ChengDu Tecbond
  • QYH Biotech
  • Elanco
  • Phibro Animal Health
  • Vetoquinol
  • Hipra
  • Venkys
  • Anicon Labor GmbH
  • Medion Farma Jaya
  • Bioveta
  • Lohmann Animal Health
  • Biogenesis Bago

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Bird Flu Market, By Virus Type
  • Global Bird Flu Market, By Test Type
  • Global Bird Flu Market, By Treatment Type
  • Global Bird Flu Market, By Animal Type
  • Global Bird Flu Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Bird Flu Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Bird Flu Market, By Virus Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• H5N1
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• H7N9
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• H5N6
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• H5N8
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• H10N8
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• H9N2
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Bird Flu Market, By Test Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• PCR Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• ELISA Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Hemagglutination Assays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Virus Isolation Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Next Generation Sequencing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Bird Flu Market, By Treatment Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Antiviral Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Immunomodulators
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Bird Flu Market, By Animal Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Chickens
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Ducks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Geese & Swans
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Pigeons
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Guinea Fowls
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Turkeys
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Bird Flu Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Virus Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Boehringer Ingelheim
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ceva Sante Animale
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Zoetis
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ringpu Biology
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Yebio Bioengineering
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• FATRO
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CAVAC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ChengDu Tecbond
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QYH Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Elanco
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Phibro Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vetoquinol
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hipra
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Venkys
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Anicon Labor GmbH
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medion Farma Jaya
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bioveta
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lohmann Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biogenesis Bago
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Section

• Research Methodology
• About us